ABSTRACT
Description: Synagis is a humanized monoclonal antibody that recognizes and binds the A antigenic site of the fusion protein of the respiratory syncytial virus (RSV). It is produced by recombinant DNA technology in a myeloma NSO cell line and is supplied in a lyophilized form to be reconstituted for intramuscular administration.
